NLL Next Level Labs
CJC-1295 + Ipamorelin 5+5 MG research vial

RESEARCH COMPOUND

Currently testing new lot, COA on the way. FINRICK A · 8.2
View third-party Finrick COA

CJC-1295 + Ipamorelin

GHRH analog and ghrelin mimetic. Pulsatile GH release research.

$90/vial

VIAL FILL

5+5 MG

UNIT VALUE

0.111 mg per dollar

Download COA, PDF.
  • Test it yourself. If it does not match our Finrick COA, full refund and you keep the vial.
  • Pay by Venmo or Zelle, instructions emailed instantly.
  • Ships in 1 to 2 days.
99.85% This batch, HPLC
Finrick A · 8.2 Third-party HPLC
$10 · FREE $200+ USPS Priority Mail, US only

  • PURITY, THIS BATCH

    99.85%

  • BATCH

    New lot in QC

  • MOLECULAR WEIGHT

    CJC-1295: 3,367.91 Da, Ipamorelin: 711.86 Da

  • SHIPPING

    US, USPS Priority Mail

For in vitro research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any condition. US shipping only.

RESEARCH OVERVIEW

About this compound.

CJC-1295 is a growth hormone releasing hormone (GHRH) analog. Ipamorelin is a selective ghrelin receptor agonist. Stacked, they are studied for synergistic effects on pulsatile growth hormone release in vitro and in animal models.

RECONSTITUTION + STORAGE

Lab handling.

RECONSTITUTION

Vials are lyophilized. Reconstitution and storage parameters should follow the recipient laboratory's standard protocols for peptide handling. Not for human consumption.

STORAGE

Lyophilized at room temp. Reconstituted, 2 to 8 degrees Celsius for up to 28 days.

RESEARCH CITATIONS

Research basis.

  • Teichman SL, et al. CJC-1295 prolonged GHRH analog, pharmacology. J Clin Endocrinol Metab. 2006.
  • Raun K, et al. Ipamorelin, selective GH secretagogue, in vitro and in vivo. Eur J Endocrinol. 1998.

Citations are listed for research context only and do not imply efficacy claims for human use.

FAQ

Common questions.

What is the CJC-1295 + Ipamorelin stack?+

A combined research stack of a GHRH analog (CJC-1295) and a ghrelin receptor agonist (Ipamorelin). Studied for pulsatile GH release in vitro.

Why are these often paired?+

Research suggests synergistic activity, GHRH driving the release while ghrelin agonism amplifies the pulse.